We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Infectious unenthusiasm

30 July 2021 By Richard Beales

There are too many companies coming to market, even excluding record numbers of blank-check vehicles. Robinhood’s vaunted offering fell flat, battery maker Clarios delayed its debut, and fruit purveyor Dole downsized. Other IPOs did better, but investors can afford to be choosy.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)